Pulike Biological Engineering, Inc. (SHA:603566)

SHA:603566 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,108	1,034	1,243	1,217	1,088	917.41
Other Revenue	10.4	8.69	10.11	13.06	11.03	11.1
Revenue	1,119	1,043	1,253	1,230	1,099	928.51
Revenue Growth (YoY)	0.09%	-16.77%	1.84%	11.97%	18.32%	40.01%
Cost of Revenue	451.47	405.63	488.4	459.74	379.95	331.25
Gross Profit	667.37	636.93	764.3	770.33	718.62	597.26
Selling, General & Admin	396.39	413.65	450.03	473.74	391.87	292.77
Research & Development	106.78	106.05	101.1	92.62	85.57	114.84
Other Operating Expenses	21.34	16.6	14.62	12.77	11.29	10.34
Operating Expenses	512.45	531.02	593.41	594.47	496.51	427.25
Operating Income	154.92	105.91	170.89	175.86	222.11	170.02
Interest Expense	-1.03	-0.08	-0.92	-0.86	-	-
Interest & Investment Income	-	4.8	21.79	10.09	2.5	15.03
Currency Exchange Gain (Loss)	-0.17	0.19	0.22	0.58	-0.22	-0.02
Other Non Operating Income (Expenses)	-2.08	-0.78	-0.73	-0.65	-0.56	0.1
EBT Excluding Unusual Items	151.65	110.03	191.25	185.02	223.84	185.12
Gain (Loss) on Sale of Investments	-9.18	-9.97	-17.69	-25.57	20.39	24.32
Gain (Loss) on Sale of Assets	-12.64	-12.27	-0.6	-0.54	-3.34	0.29
Asset Writedown	-1	-1	-0.03	-	-	-
Other Unusual Items	18.9	11.98	21.68	18.81	43.28	50.28
Pretax Income	147.72	98.76	194.61	177.72	284.18	260
Income Tax Expense	12.68	5.96	20.1	9.9	40.04	32.26
Net Income	135.04	92.81	174.52	167.82	244.14	227.74
Net Income to Common	135.04	92.81	174.52	167.82	244.14	227.74
Net Income Growth	1.98%	-46.82%	3.99%	-31.26%	7.20%	108.47%
Shares Outstanding (Basic)	339	344	349	323	313	316
Shares Outstanding (Diluted)	339	344	349	323	313	316
Shares Change (YoY)	-4.49%	-1.52%	8.15%	3.11%	-1.05%	-1.56%
EPS (Basic)	0.40	0.27	0.50	0.52	0.78	0.72
EPS (Diluted)	0.40	0.27	0.50	0.52	0.78	0.72
EPS Growth	6.78%	-46.00%	-3.85%	-33.33%	8.33%	111.77%
Free Cash Flow	337.39	147.73	-22.2	-128.8	-105.01	84.69
Free Cash Flow Per Share	1.00	0.43	-0.06	-0.40	-0.34	0.27
Dividend Per Share	0.600	0.400	0.700	0.350	0.200	0.500
Dividend Growth	-14.29%	-42.86%	100.00%	75.00%	-60.00%	150.00%
Gross Margin	59.65%	61.09%	61.01%	62.63%	65.41%	64.33%
Operating Margin	13.85%	10.16%	13.64%	14.30%	20.22%	18.31%
Profit Margin	12.07%	8.90%	13.93%	13.64%	22.22%	24.53%
Free Cash Flow Margin	30.16%	14.17%	-1.77%	-10.47%	-9.56%	9.12%
EBITDA	276.44	225.17	262.7	249.8	281.42	221.07
EBITDA Margin	24.71%	21.60%	20.97%	20.31%	25.62%	23.81%
D&A For EBITDA	121.51	119.26	91.81	73.93	59.31	51.05
EBIT	154.92	105.91	170.89	175.86	222.11	170.02
EBIT Margin	13.85%	10.16%	13.64%	14.30%	20.22%	18.31%
Effective Tax Rate	8.58%	6.03%	10.33%	5.57%	14.09%	12.41%
Revenue as Reported	1,119	1,043	1,253	1,230	1,099	928.51
Advertising Expenses	-	10.27	5.54	7.62	7.54	6.19

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.